Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-11-005656
Filing Date
2011-08-09
Accepted
2011-08-09 16:14:10
Documents
14
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ugne_10q-063011.htm 10-Q 790220
2 EXHIBIT 10.3 ex10-3.htm EX-10.3 171348
3 EXHIBIT 10.4 ex10-4.htm EX-10.4 74005
4 EXHIBIT 10.5 ex10-5.htm EX-10.5 142214
5 EXHIBIT 31.1 ex31-1.htm EX-31.1 15496
6 EXHIBIT 31.2 ex31-2.htm EX-31.2 14901
7 EXHIBIT 32.1 ex32-1.htm EX-32.1 6684
8 EXHIBIT 32.2 ex32-2.htm EX-32.2 6527
  Complete submission text file 0001437749-11-005656.txt   3507928

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE ugne-20110630.xml EX-101.INS 402887
10 XBRL TAXONOMY EXTENSION SCHEMA ugne-20110630.xsd EX-101.SCH 23129
11 XBRL TAXONOMY EXTENSION CALCULATION ugne-20110630_cal.xml EX-101.CAL 38606
12 XBRL TAXONOMY EXTENSION DEFINITION ugne-20110630_def.xml EX-101.DEF 105075
13 XBRL TAXONOMY EXTENSION LABELS ugne-20110630_lab.xml EX-101.LAB 147051
14 XBRL TAXONOMY EXTENSION PRESENTATION ugne-20110630_pre.xml EX-101.PRE 121727
Mailing Address 81 FULTON STREET BOONTON NJ 07005
Business Address 81 FULTON STREET BOONTON NJ 07005 973-265-1100
UNIGENE LABORATORIES INC (Filer) CIK: 0000352747 (see all company filings)

EIN.: 222328609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-16005 | Film No.: 111020940
SIC: 2833 Medicinal Chemicals & Botanical Products